Schizophrenia Center

  • News
Schizophrenia Rx Gets Stronger Warning
The US Food and Drug Administration (FDA) has strengthened a drug safety warning for a schizophrenia medication.
A Patch for Schizophrenia
The US Food and Drug Administration (FDA) has approved a first-of-its-kind patch for schizophrenia.
First Digital Medication Approved
Abilify MyCite is the first digital medication system approved by the US Food and Drug Administration (FDA).
First Tardive Dyskinesia Rx Approved
The US Food and Drug Administration (FDA) has approved the first drug to treat tardive dyskinesia.
Schizophrenia Rx Now Approved for Teens
The US Food and Drug Administration (FDA) has approved a new treatment for teens with schizophrenia.
A New Warning for Olanzapine
The US Food and Drug Administration (FDA) is warning about the possibility for a rare but serious skin reaction from a particular antipsychotic.
New Warning For Aripiprazole
The US Food and Drug Administration (FDA) is warning about possible impulse-control problems, such as compulsive or uncontrollable urges, tied to a particular antipsychotic.
Spotting the Treatment Gap in Diabetes Screening
Patients with severe mental illness face an increased risk for diabetes. And new evidence suggests there may be room for improvement when it comes to screening these patients for the condition.
A Shot for Schizophrenia
After a new FDA approval, patients who face schizophrenia every day may not have to take their medication every day to stay healthy.
Mental Health Rx Gets Go-Ahead
A newly approved medication could help some patients with serious mental health disorders.
Among Teens, Antipsychotics May Be Too Common
Mental illness consists of an array of complex and hard-to-pin-down disorders, but avoiding misdiagnosis can be crucial to treating it properly.
Under Debate: Psychiatric Medications
Medications are often prescribed to treat mental conditions, but are they all they’re cracked up to be? Some have raised concerns that psychiatric medications may have overstated benefits and underreported harms.
First-Ever Generic Abilify Gets FDA Go-Ahead
Four pharmaceutical companies received approval today from the US Food and Drug Administration (FDA) to market generic versions of Abilify, an atypical antipsychotic drug.
How Marijuana May Change Teen Brains
Teens often experiment with substances like marijuana, but abusing marijuana may pose a threat to memory abilities.
Heart Problems May Start Early on in Schizophrenia
A mental illness can affect almost every part of life — including heart health, say the authors of a new study.
Injectable Schizophrenia Medications: The Old vs the New
Schizophrenia can be treated with oral or injectable medications. The injections last longer and may help to keep patients from stopping treatment. But it's still unclear if newer injectable medications work better than the older ones.
Better Mental Health, Less Crime
People with mental illnesses are more likely to be victims of crimes than to commit violent crimes. But there remain some outliers among those with psychiatric disorders who do commit violent crimes.
Smokers May Need Different Doses of Antipsychotics
Getting the correct dose of medication into the bloodstream means patients get the most from their medications. However, smoking may affect that process.
Medicine to Help Mental Health Patients Quit Smoking
A cigarette habit can be hard to kick, especially for people with serious mental illnesses. Luckily, there's a medication that might make the quitting process easier.
Psychotic Disorders and Addiction Linked
Sometimes those with mental disorders can also experience other types of physical or mental illness. One such mental illness they may be at risk for is addiction.
More